🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to determine whether the recurrence rate of high-risk acute...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-01-01
Trial ID
NCT07101588
Treatments Being Tested
This is a multi-center, single-arm, open-label, phase II trial for the fron...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2020-02-17
Trial ID
NCT04055844
Treatments Being Tested
This study observes the safety and efficacy of Azacitidine (AZA) combined w...
Status
Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2022-11-01
Trial ID
NCT05817955
Treatments Being Tested
This phase I trial studies the side effects and best dose of ruxolitinib wh...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2019-08-16
Trial ID
NCT03874052
This is an open-label, dose-escalation study of the proviral integration si...
Status
Terminated
Location
The University of Arizona Cancer Center
Start Date
2015-12-29
Trial ID
NCT02587598
Treatments Being Tested
The purpose of the Study is to select a dose and assess the safety and tole...
Status
Terminated
Location
University of Alabama
Start Date
2016-05-18
Trial ID
NCT02711137
Treatments Being Tested
This phase I trial studies the side effects and best dose of ruxolitinib (R...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2026-04-21
Trial ID
NCT07548983
Treatments Being Tested
This phase II trial studies how well ruxolitinib phosphate and azacytidine ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2013-03-13
Trial ID
NCT01787487
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ruxolitinib...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-02-12
Trial ID
NCT02257138
Treatments Being Tested
This phase II trial studies how well decitabine with ruxolitinib, fedratini...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-03-24
Trial ID
NCT04282187
Treatments Being Tested